SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
SEC Accession No. 0001104659-22-022771
Filing Date
2022-02-14
Accepted
2022-02-14 16:11:50
Documents
1
Group Members
PETER KOLCHINSKYRA CAPITAL HEALTHCARE FUND, L.P.RAJEEV SHAH

Document Format Files

Seq Description Document Type Size
1 CYTOMX THERAPEUTICS, INC. tm225316d3_sc13ga.htm SC 13G/A 92270
  Complete submission text file 0001104659-22-022771.txt   93978
Mailing Address 200 BERKELEY STREET, 18TH FLOOR BOSTON MA 02116
Business Address 200 BERKELEY STREET, 18TH FLOOR BOSTON MA 02116 617-778-2500
RA CAPITAL MANAGEMENT, L.P. (Filed by) CIK: 0001346824 (see all company filings)

IRS No.: 830406777 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A

Mailing Address 151 OYSTER POINT BLVD. SUITE 400 SOUTH SAN FRANCISCO CA 94080
Business Address 151 OYSTER POINT BLVD. SUITE 400 SOUTH SAN FRANCISCO CA 94080 650.515.3185
CytomX Therapeutics, Inc. (Subject) CIK: 0001501989 (see all company filings)

IRS No.: 273521219 | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-89140 | Film No.: 22631933
SIC: 2834 Pharmaceutical Preparations